Marius Pharmaceuticals   Report issue

For profit Phase 3
Founded: Raleigh NC United States (2017)
Status: No NME R&D (2017)

Organization Overview

First Clinical Trial
2017
NCT03198728
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Marius Pharmaceuticals

Active Ingredients

Drugs in Phase 3 Trials (1)

testosterone (delatestryl) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Eunuchism (Phase 3)

Hypogonadism (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1